Immediate Impact

22 standout
Sub-graph 1 of 11

Citing Papers

Advances in diagnosis and treatment of bladder cancer
2024 Standout
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 Standout
5 intermediate papers

Works of Wilson Sui being referenced

Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non–muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy
2017
A phase I trial for the use of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) in the treatment of BCG-refractory nonmuscle invasive urothelial carcinoma of the bladder.
2017
and 3 more

Author Peers

Author Last Decade Papers Cites
Wilson Sui 354 153 51 143 49 532
Hagen Loertzer 327 160 63 146 51 544
O Leiva 393 165 79 86 34 645
Michele Rizzo 253 168 42 165 66 575
Anuar Ibrahim Mitre 295 224 131 158 50 516
M. Bürger 307 110 38 128 48 539
Ramanitharan Manikandan 164 210 86 168 67 495
Uttam Mete 161 192 57 175 45 506
Frank J. Leary 311 207 104 117 34 645
Nicola Frego 223 127 30 112 62 608
Abhinav Khanna 261 258 40 180 59 625

All Works

Loading papers...

Rankless by CCL
2026